Cargando…
Synthesis of C‐14 labeled GABA(A) α2/α3 selective partial agonists and the investigation of late‐occurring and long‐circulating metabolites of GABA(A) receptor modulator AZD7325
Anxiolytic activity has been associated with GABA(A) α2 and α3 subunits. Several target compounds were identified and required in C‐14 labeled form to enable a better understanding of their drug metabolism and pharmacokinetic properties. AZD7325 is a selective GABA(A) α2 and α3 receptor modulator in...
Autores principales: | Artelsmair, Markus, Gu, Chungang, Lewis, Richard J., Elmore, Charles S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969218/ https://www.ncbi.nlm.nih.gov/pubmed/29314165 http://dx.doi.org/10.1002/jlcr.3602 |
Ejemplares similares
-
α subunits in GABA(A) receptors are dispensable for GABA and diazepam action
por: Wongsamitkul, Nisa, et al.
Publicado: (2017) -
Repositioning of a novel GABA-B receptor agonist, AZD3355 (Lesogaberan), for the treatment of non-alcoholic steatohepatitis
por: Bhattacharya, Dipankar, et al.
Publicado: (2021) -
Gamma-Aminobutyric Acid (GABA) Inhibits α-Melanocyte-Stimulating Hormone-Induced Melanogenesis through GABA(A) and GABA(B) Receptors
por: Molagoda, Ilandarage Menu Neelaka, et al.
Publicado: (2021) -
Preliminary effects of pagoclone, a partial GABA(A) agonist, on neuropsychological performance
por: Caveney, Angela F, et al.
Publicado: (2008) -
Pharmacokinetic Profile of Lesogaberan (AZD3355) in Healthy Subjects: A Novel GABA(B)-Receptor Agonist Reflux Inhibitor
por: Niazi, Mohammad, et al.
Publicado: (2012)